Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Hyaluronidase + articain** is a combination of two drugs used adjunctively in dental and soft-tissue procedures. **Articain** is a local anesthetic of the amide type with enhanced bone penetration properties, often used for local or regional anesthesia in dental surgery. **Hyaluronidase** is an enzyme that increases tissue permeability by depolymerizing hyaluronic acid in the extracellular matrix, enhancing the diffusion and absorption of co-administered drugs like local anesthetics. When used together, hyaluronidase may improve onset and duration of soft tissue anesthesia achieved by articaine, though clinical studies suggest its primary benefit is in prolonging soft tissue anesthesia and shortening onset time, without significantly improving pulpal anesthesia. This combination may be considered for dental procedures especially where extended soft tissue anesthesia and rapid onset are desired, such as in periodontal surgeries and complex biopsies[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hyaluronidase + articain.